BioCentury
ARTICLE | Company News

VivoRx, Mylan Laboratories Inc. gene/cell therapy, metabolic news

March 29, 1999 8:00 AM UTC

Mylan said it has discontinued research funding to VivoRx and filed suit in Los Angeles County Superior Court against VivoRx, the company's directors and officers and other companies owned or controlled by VivoRx's officers and directors for alleged improprieties regarding the funding. Mylan had been funding development of VivoRx's encapsulated cell therapies to treat diabetes in exchange for North American marketing rights since 1994. ...